MedTrace Logo

Mechanisms of Anaphylaxis

NCT03182491 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2022-08-03

No results posted yet for this study

Summary

The purpose of this study is to explore different mechanisms for anaphylaxis and find novel biomarkers for this hypersensitivity syndrome. The study participants are patients with anaphylaxis, patients with mild allergic reactions, and patients with febrile transfusion reactions. The investigators will also include a group of healthy controls.

Conditions

  • Anaphylaxis
  • Allergy
  • Transfusion Reaction
  • Febrile Transfusion Reaction

Interventions

DIAGNOSTIC_TEST

Biomarkers (platelet activating factor [PAF], anaphylatoxins) and basophil activation test (BAT)

Analysis of biomarkers and basophil activation test

Sponsors & Collaborators

  • Haukeland University Hospital

    lead OTHER

Principal Investigators

  • Torunn O Apelseth, MD, PhD · Haukeland University Hospital

  • Morten Y Isaksen, MD · Haukeland University Hospital

Eligibility

Min Age
16 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-28
Primary Completion
2026-10-01
Completion
2026-10-01

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03182491 on ClinicalTrials.gov